These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 35215938)
21. Lesions and Cellular Tropism of Natural Rift Valley Fever Virus Infection in Young Lambs. Odendaal L; Davis AS; Fosgate GT; Clift SJ Vet Pathol; 2020 Jan; 57(1):66-81. PubMed ID: 31842723 [TBL] [Abstract][Full Text] [Related]
22. Rift Valley fever virus modulates apoptosis and immune response during infection of human astrocytes. Quellec J; Pédarrieu A; Piro-Mégy C; Barthelemy J; Simonin Y; Salinas S; Cêtre-Sossah C Emerg Microbes Infect; 2023 Dec; 12(1):2207672. PubMed ID: 37306630 [TBL] [Abstract][Full Text] [Related]
23. Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis. Wonderlich ER; Caroline AL; McMillen CM; Walters AW; Reed DS; Barratt-Boyes SM; Hartman AL J Virol; 2018 Feb; 92(3):. PubMed ID: 29118127 [TBL] [Abstract][Full Text] [Related]
24. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus]. Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371 [TBL] [Abstract][Full Text] [Related]
25. A new mouse model reveals a critical role for host innate immunity in resistance to Rift Valley fever. do Valle TZ; Billecocq A; Guillemot L; Alberts R; Gommet C; Geffers R; Calabrese K; Schughart K; Bouloy M; Montagutelli X; Panthier JJ J Immunol; 2010 Nov; 185(10):6146-56. PubMed ID: 20937849 [TBL] [Abstract][Full Text] [Related]
26. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection. López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044 [TBL] [Abstract][Full Text] [Related]
27. Innate Immune Basis for Rift Valley Fever Susceptibility in Mouse Models. Lathan R; Simon-Chazottes D; Jouvion G; Godon O; Malissen M; Flamand M; Bruhns P; Panthier JJ Sci Rep; 2017 Aug; 7(1):7096. PubMed ID: 28769107 [TBL] [Abstract][Full Text] [Related]
28. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment. Scharton D; Bailey KW; Vest Z; Westover JB; Kumaki Y; Van Wettere A; Furuta Y; Gowen BB Antiviral Res; 2014 Apr; 104():84-92. PubMed ID: 24486952 [TBL] [Abstract][Full Text] [Related]
29. Human immune cell engraftment does not alter development of severe acute Rift Valley fever in mice. Spengler JR; McElroy AK; Harmon JR; Coleman-McCray JD; Welch SR; Keck JG; Nichol ST; Spiropoulou CF PLoS One; 2018; 13(7):e0201104. PubMed ID: 30028878 [TBL] [Abstract][Full Text] [Related]
30. Cytokine response in mouse bone marrow derived macrophages after infection with pathogenic and non-pathogenic Rift Valley fever virus. Roberts KK; Hill TE; Davis MN; Holbrook MR; Freiberg AN J Gen Virol; 2015 Jul; 96(Pt 7):1651-1663. PubMed ID: 25759029 [TBL] [Abstract][Full Text] [Related]
31. Identification of Host Factors for Rift Valley Fever Phlebovirus. Balaraman V; Indran SV; Li Y; Meekins DA; Jakkula LUMR; Liu H; Hays MP; Souza-Neto JA; Gaudreault NN; Hardwidge PR; Wilson WC; Weber F; Richt JA Viruses; 2023 Nov; 15(11):. PubMed ID: 38005928 [TBL] [Abstract][Full Text] [Related]
32. Resistance to Rift Valley fever virus in Rattus norvegicus: genetic variability within certain 'inbred' strains. Ritter M; Bouloy M; Vialat P; Janzen C; Haller O; Frese M J Gen Virol; 2000 Nov; 81(Pt 11):2683-2688. PubMed ID: 11038380 [TBL] [Abstract][Full Text] [Related]
33. Culex flavivirus infection in a Culex pipiens mosquito colony and its effects on vector competence for Rift Valley fever phlebovirus. Talavera S; Birnberg L; Nuñez AI; Muñoz-Muñoz F; Vázquez A; Busquets N Parasit Vectors; 2018 May; 11(1):310. PubMed ID: 29792223 [TBL] [Abstract][Full Text] [Related]
34. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania. Nyundo S; Adamson E; Rowland J; Palermo PM; Matiko M; Bettinger GE; Wambura P; Morrill JC; Watts DM Onderstepoort J Vet Res; 2019 Jan; 86(1):e1-e8. PubMed ID: 30843406 [TBL] [Abstract][Full Text] [Related]
35. The pathogenesis of Rift Valley fever. Ikegami T; Makino S Viruses; 2011 May; 3(5):493-519. PubMed ID: 21666766 [TBL] [Abstract][Full Text] [Related]
36. Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain. Ly HJ; Nishiyama S; Lokugamage N; Smith JK; Zhang L; Perez D; Juelich TL; Freiberg AN; Ikegami T Vaccine; 2017 Dec; 35(48 Pt B):6634-6642. PubMed ID: 29061350 [TBL] [Abstract][Full Text] [Related]
38. Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse. Gray KK; Worthy MN; Juelich TL; Agar SL; Poussard A; Ragland D; Freiberg AN; Holbrook MR PLoS Negl Trop Dis; 2012; 6(2):e1529. PubMed ID: 22389738 [TBL] [Abstract][Full Text] [Related]
39. RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge. Ermler ME; Yerukhim E; Schriewer J; Schattgen S; Traylor Z; Wespiser AR; Caffrey DR; Chen ZJ; King CH; Gale M; Colonna M; Fitzgerald KA; Buller RM; Hise AG J Virol; 2013 May; 87(9):4846-60. PubMed ID: 23408632 [TBL] [Abstract][Full Text] [Related]
40. Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model. Dodd KA; McElroy AK; Jones TL; Zaki SR; Nichol ST; Spiropoulou CF PLoS Negl Trop Dis; 2014 Jun; 8(6):e2874. PubMed ID: 24922480 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]